Glycinergic input to the mouse basal forebrain cholinergic neurons by Bardóczi, Zsuzsanna et al.
Systems/Circuits
Glycinergic Input to the Mouse Basal Forebrain Cholinergic
Neurons
Zsuzsanna Bardo´czi,1,2 Bala´zs Pa´l,3 A´ron Ko˝szeghy,3 Tama´sWilheim,1,6 XMasahikoWatanabe,4 La´szlo´ Za´borszky,5
Zsolt Liposits,1,6 and XImre Kallo´1,6
1Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, HAS, 1083, Budapest, Hungary, 2Semmelweis University, School of PH.D.
Studies, 1085, Budapest, Hungary, 3Department of Physiology, Faculty of Medicine, University of Debrecen, 4032, Debrecen, Hungary, 4Department of
Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan, 5Center for Molecular and Behavioral Neuroscience, Rutgers, Newark,
New Jersey 07102, and 6Department of Neuroscience, Faculty of Information Technology, Pa´zma´ny Pe´ter Catholic University, 1083, Budapest, Hungary
The basal forebrain (BF) receives afferents frombrainstemascending pathways, which has been implicated first byMoruzzi andMagoun
(1949) to induce forebrain activation and cortical arousal/waking behavior; however, it is very little known about how brainstem inhib-
itory inputs affect cholinergic functions. In the current study, glycine, a major inhibitory neurotransmitter of brainstem neurons, and
gliotransmitter of local glial cells, was tested for potential interaction with BF cholinergic (BFC) neurons inmalemice. In the BF, glycine
receptor subunit-immunoreactive (IR) siteswere localized in choline acetyltransferase (ChAT)-IRneurons.The effect of glycineonBFC
neurons was demonstrated by bicuculline-resistant, strychnine-sensitive spontaneous IPSCs (sIPSCs; 0.81 0.25 101 Hz) recorded
in whole-cell conditions. Potential neuronal as well as glial sources of glycine were indicated in the extracellular space of cholinergic
neurons by glycine transporter type 1 (GLYT1)- and GLYT2-IR processes found in apposition to ChAT-IR cells. Ultrastructural analyses
identified synapses of GLYT2-positive axon terminals on ChAT-IR neurons, as well as GLYT1-positive astroglial processes, which were
localized in thevicinityof synapsesofChAT-IRneurons.Thebrainstemraphemagnuswasdeterminedtobeamajorsourceofglycinergicaxons
tracedretrogradely fromtheBF.Ourresults indicateadirecteffectofglycineonBFCneurons.Furthermore, thepresenceofhigh levelsofplasma
membrane glycine transporters in the vicinity of cholinergic neurons suggests a tight control of extracellular glycine in the BF.
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Introduction
Forebrain activation and cortical arousal/waking behavior are
thought to be critically influenced by ascending pathways deriv-
ing from the brainstem (Buzsaki et al., 1988; Steriade and
Timofeev, 2002; Sutcliffe and de Lecea, 2002; Zaborszky and
Duque, 2003; Saper et al., 2005; Datta and Maclean, 2007; Fuller
et al., 2011; Luppi et al., 2013). These axons form a ventral path-
way targeting the basal forebrain (BF), including its cholinergic
corticopetal neurons and hypocretin/MCHneurons in the hypo-
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Significance Statement
Basal forebrain cholinergic (BFC) neurons receive various activating inputs from specific brainstem areas and channel this
information to the cortex via multiple projections. So far, very little is known about inhibitory brainstem afferents to the BF. The
current study established glycine as a major regulator of BFC neurons by (1) identifying glycinergic neurons in the brainstem
projecting to the BF, (2) showing glycine receptor  subunit-immunoreactive (IR) sites in choline acetyltransferase (ChAT)-IR
neurons, (3) demonstrating glycine transporter type 2 (GLYT2)-positive axon terminals synapsing on ChAT-IR neurons, and
(4) localizing GLYT1-positive astroglial processes in the vicinity of synapses of ChAT-IR neurons. The effect of glycine on BFC
neurons was demonstrated by bicuculline-resistant, strychnine-sensitive spontaneous IPSCs recorded in whole-cell conditions.
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thalamus and a dorsal pathway innervating thalamic nuclei. The
dorsal pathway contains glutamatergic and cholinergic pro-
jections from the mesopontine tegmentum (Luppi et al.,
2013). Catecholaminergic and glutamatergic ascending axons
have been suggested to contact cholinergic neurons in the BF
and GABAergic neurons in the ventrolateral preoptic nucleus
(Luppi et al., 2013; Zaborszky et al., 2015). In addition, it has been
shown that hypocretin axons synapse with septal cholinergic
neurons and depolarize them (Wu et al., 2004). Recently a gly-
cinergic pathway has been described deriving from the pontine
reticular formation and targeting the intralaminar thalamic nu-
clei; optogenetic stimulation of the contributing cell population
in mice evoked behavioral arrest and transient interruption of
awake cortical activity (Giber et al., 2015).
A potential role for glycine in the BF has also been postulated
in our previous study (Bardo´czi et al., 2013) based on the
presence of membrane glycine transporter type 1 (GLYT1)
and GLYT2. GLYTs, depending on their location, have distinct
functions at glycinergic synapses. GLYT2 provides glycine for the
refilling of presynaptic vesicles of glycinergic neurons (Gomeza et
al., 2003), whereas GLYT1 ensures the removal of glycine from
the synaptic cleft into glial cells, leading to the termination of
glycine-mediated neurotransmission. In addition, GLYT1 is also
present in certain glutamatergic neurons and regulates the con-
centration of glycine at excitatory synapses containing NMDA
receptors, which are known to require glycine as a coagonist (Eu-
lenburg et al., 2005).
BF areas [i.e., the medial septum (MS), vertical limb of the
diagonal band of Broca (VDB), horizontal limb of the diagonal
band of Broca (HDB), ventral pallidum (VP), and the substantia
innominate (SI)] contain a heterogeneous collection of cholin-
ergic, GABAergic, glutamatergic projection neurons, and various
interneurons (for review, see Zaborszky et al., 2015). The large
cholinergic neurons are wake-promoting neurons, as are the gluta-
matergic and parvalbumin-positive GABAergic neurons, which are
more active during wakefulness and rapid eye movement (REM)
sleep (wake/REM active) than during non-REM (NREM) sleep.
Optogenetic activation of these neurons rapidly induces wakeful-
ness, contrasting with somatostatin-positive GABAergic neu-
rons, the stimulation of which promotes NREM sleep (Xu et al.,
2015). However, chemogenetic activation of BF cholinergic or
glutamatergic neurons in behaving mice has no effect on total
wakefulness. In contrast, similar chemogenetic activation of BF
GABAergic neurons produces sustained wakefulness and high-
frequency cortical rhythms (Anaclet et al., 2015). Other data sug-
gest that specific types of BF neurons play distinct roles in cortical
(Kim et al., 2015) and hippocampal oscillations (Sotty et al.,
2003) or in inducing hippocampal LTP or LTD (Gu and Yakel,
2011). Thus, it is very important to define which types of BF
neurons are regulated by glycine.
The aim of the present study was to define whether the func-
tion of BF cholinergic neurons is influenced by glycine. Confocal
and electron microscopic studies were used to characterize the
morphological relationship of choline acetyltransferase (ChAT)-
immunoreactive (IR) neurons with GLYT1- and/or GLYT2-IR
cellular processes. In addition, in vitro patch-clamp electro-
physiology was used to demonstrate the effect of glycine on
cholinergic neurons. Our results indicate that glycine has a di-
rect influence on BF cholinergic (BFC) neurons by demonstrat-
ing (1) bicuculline-resistant, strychnine-sensitive spontaneous
IPSCs; (2) synaptic connections between glycinergic and cholin-
ergic neurons; and (3) strong presence of glycine transporters in
glial and neuronal processes in the vicinity of cholinergic neu-
rons. The primary origin of glycinergic axons of the BF is the




Wild-type (CD1, Charles River; n  21) and transgenic male mice ex-
pressing the fluorescent reporter proteins eGFP (GLYT2-eGFP, Zeil-
hofer et al., 2005; n 12, and ChATBAC-eGFP, The Jackson Laboratory;
n 3), or tdTomato ((ChATCRE-tdTomato,n 26), generated by cross-
breeding of ChAT-CREmice (Rossi et al., 2011, http://www.informatics.
jax.org/reference/J:114556; JAX mice catalog #006410; n  2) and
floxed-stop-tdTomato reporter mice (Madisen et al., 2010, JAX mice
catalog #007905; n 6)) were used.Mice (1–3months old, 25–30 g body
weight) were housed under controlled lighting (12 h light/dark cycle;
lights on at 7:00 A.M., zeitgeber time 0) and temperature (22 2°C)with
access to food and water ad libitum. Studies were performed with per-
mission from the Animal Welfare Committee of the Institute of Experi-
mental Medicine (No. 2285/003) and Debrecen University (No.
6/2011/DE MA´B and 5/2015/DEMA´B) and in accordance with legal re-
quirements of the European Community (Decree 86/609/EEC). Surgery
was performed on animals under deep anesthesia induced by an intra-
peritoneally injected cocktail of ketamine (25 mg/kg body weight), Xy-
lavet (5 mg/kg body weight), and Pipolphen (2.5 mg/kg body weight) in
saline.
Anatomical studies
Tissue preparation. Mice were perfused transcardially with PBS (0.1 M)
containing 4% paraformaldehyde (PFA). The brains were postfixed in
2%PFA/PBS solution for 24 h at 4°C and cryoprotected overnight in 25%
sucrose, and 25-m-thick coronal sections were cut from a block of the
basal forebrain expanding between bregma 1.3 and 1.3 mm on a
freezing microtome. The sections were divided into three sequential
pools (30–35 sections in each set, with 50 m gaps between consecu-
tive sections) and stored in antifreeze solution [30% ethylene glycol; 25%
glycerol; 0.05 M phosphate buffer (PB); pH 7.4] at20°C until use. For
mapping the immunolabeled cells and cellular profiles, a set of sections
from each brain was Nissl counterstained, photographed, and matched
with the corresponding atlas figures. After the endogenous peroxidase
activity had been quenched with 0.5% hydrogen peroxide (10 min), sec-
tions were permeabilized with 0.5% Triton X-100 (catalog #23,472-9,
Sigma-Aldrich; 20 min). Finally, 2% normal horse serum (NHS) was
applied (for 20min) to reduce nonspecific antibody binding. Subsequent
treatments and interim rinses in PBS (3 for 5 min) were performed at
room temperature, except for incubation in the primary antibody or
fluorochrome conjugate, which took place at 4°C.
Double-labeling for GLYT1 or GLYT2 and ChAT immunoreactivity.
Sections from the BF region of CD1 mice were incubated in goat anti-
GLYT1 (1:10,000; catalog #AB1770, Millipore; RRID:AB_90893) or rab-
bit anti-GLYT2 [1g/ml; #N30aa, a gift fromM.W. (Hondo et al., 2011);
RRID:AB_2571606] primary antibodies. GLYT1 and GLYT2 immuno-
reactivities were visualized with biotinylated donkey anti-goat IgG (dilu-
tion, 1:500; 2 h; catalog #705-065-147, Jackson ImmunoResearch) or
biotinylated donkey anti-rabbit IgG (dilution, 1:500; 2 h; catalog #711-
065-152, Jackson ImmunoResearch) and Vectastain ABC Elite solution
(dilution 1:1000; 1.5 h; PK-6100, Vector Laboratories), then the signal
was detected with nickel-intensified diaminobenzidine (NiDAB). The
NiDAB reaction product was further intensified by the application of a
special physical developer producing silver precipitate on NiDAB, which
was then stabilizedwith gold toning (silver-gold intensifiedNiDAB, SGI-
NiDAB; Kallo´ et al., 2001), similar to the method described before for
DAB (Liposits et al., 1984). Due to the relatively large difference in the
argyrophilia of NiDAB and the nervous tissue and the minimal immu-
nohistochemical background, suppression of tissue argyrophilia with
thioglycolic acid was unnecessary and omitted from the protocol. Subse-
quently, the sections were incubated in goat anti-ChAT (1:1500; catalog
#AB144P-1ML, Millipore; RRID:AB_262156), which was detected with
biotinylated donkey anti-goat IgG (dilution, 1:500; overnight; Jackson
ImmunoResearch), and ABC Elite solution (dilution, 1:500; 1.5 h), pro-
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viding that the metallic shield (i.e., SGI-NiDAB) formed around the
antigen–antibody complex prevents unwanted binding of Igs used for
the detection of the second tissue antigen (Liposits et al., 1986). The
ChAT-IR sites were visualized with DAB.
Immunofluorescent detection and 3D reconstruction of GLYT1- and
GLYT2-IR profiles. Sections containing the BF of ChATBAC-eGFP mice
were incubated in a mixture of goat anti-GLYT1 (1: 10,000; catalog
#AB1770, Millipore; RRID:AB_90893) and rabbit anti-GLYT2 (N30aa;
1 g/ml) primary antibodies (for 48 h). Then they were sequentially
incubated in biotinylated donkey anti-goat IgG (dilution, 1:500; 2 h;
catalog #705-065-147, Jackson ImmunoResearch), Vectastain ABC Elite
solution (dilution, 1:1000; 1 h), biotinylated tyramide with H2O2 (dilu-
tion, 1:1000 and 0.006%, respectively; 0.5 h). Finally, the GLYT1-linked
labeling complexes and the GLYT2–anti-GLYT2 complexes were visual-
ized, respectively, with Alexa Fluor 594-Streptavidin (dilution, 1:500;
12 h; S-11227, Invitrogen) and CY5-conjugated donkey anti-rabbit IgG
(dilution, 1: 1000; overnight; catalog #711-175-152, Jackson ImmunoRe-
search). The double-labeled sections (i.e., for GLYT1 and GLYT2) con-
taining the eGFP-expressing ChAT neurons were imaged using a Nikon
A1 Confocal Microscope. Multiple stacks of optical slices (1024 1024
pixels; z-steps, 0.6 m) were obtained by scanning selected areas with
cholinergic neurons of the different subdivisions of BF using a 60 oil-
immersion objective. To detect eGFP, Alexa Fluor 594, and CY5, laser
lines of 488, 594, and 633 nm, and dichroic/emission filters 560/500–530,
650/565–625, and 660 nm long-pass filters were used, respectively. The
emission images were recorded separately in green, red, and blue chan-
nels andwere displayedwith the ImageJ software. Appositionswere iden-
tified at the orthogonal view of the confocal z-stacks, and the image was
generated by reconstructing the labeled profiles in 3D using the Amira
software (FEI Visualization Sciences Group).
Tissue preparation for electron microscopy. To investigate the morpho-
logical relationship of cholinergic neurons with plasma membrane
glycine transporter-containing processes in the BF at the electronmicro-
scopic level, pre-embedding, double-label immunohistochemistry was
performed. CD1mice were deeply anesthetized and perfused transcardi-
ally, first with 10 ml of 0.01 M PBS, pH 7.4, followed by 30 ml of 2%
PFA/4% acrolein in 0.1 M PB, pH 7.4, and then 10 ml of 4% PFA in the
same buffer. The brains were rapidly removed and fixed further in 4%
PFA overnight at 4°C and then stored in PBS for 24 h at 4 C°. Thirty-
micrometer-thick coronal sectionswere cut with a vibratome and treated
with 1% sodium borohydride (30 min) and 0.5% H2O2 (15 min) and
permeabilized with three freeze–thaw cycles, as described previously (Jo
et al., 2012).
Pre-embedding detection of GLYT1 or GLYT2 and ChAT-IRs. Sections
of the BF were double labeled for ChAT and GLYT1- or GLYT2-IR, as
described above for bright-field microscopy mapping. The double-
labeled sections were then treated with 1% osmium tetroxide (1 h) and
2% uranyl acetate (in 70% ethanol; 40 min), dehydrated in an ascending
series of ethanol and propylene oxide, and flat embedded in TAAB 812
medium epoxy resin between glass microscope slides precoated with a
liquid release agent (catalog #70880, ElectronMicroscopy Sciences). The
resin was allowed to polymerize at 56°C for 2 d. The flat-embedded
sections were initially investigated by light microscopy at 60 magnifi-
cation; areas exhibiting appositions of GLYT1- or GLYT2-IR processes
on the somatodendritic region of ChAT-IR neurons were selected for
further processing. Semithin (1 m) and ultrathin (50–60 nm) sections
were cut with a Leica Microsystems ultracut UCT ultramicrotome. The
ultrathin sections were collected in ribbons onto Formvar-coated single-
slot grids, contrasted with 2% lead citrate and examinedwith a Jeol 100 C
Transmission Electron Microscope.
Demonstration of glycine receptor-IR in cholinergic neurons. To detect
glycine receptor (GlyR)-IR, sections of CD1 or ChAT-eGFPmice (n 4)
were subjected to pepsin (1mg/ml in 0.2NHCl;DAKO)pretreatment for
2–3min at 37°C. After blocking nonspecific antibody binding with 2%
NHS (20 min) sections were incubated (72 h) in a cocktail of the
guinea pig anti-GlyR [1 g/ml; #105-136aa, a gift from Masahiko
Watanabe, Hokkaido University (Hondo et al., 2011); RRID:
AB_2571771] and goat anti-ChAT (1:1500; catalog #AB144P-1ML,Mil-
lipore; RRID:AB_262156), or rabbit anti-GFP (1:2500; catalog
#AB10145,Millipore; RRID:AB_1587096) primary antibodies. GlyR im-
munoreactivity was visualized with biotinylated donkey anti-guinea pig
(1:1000; 2 h; catalog #711-065-152, Jackson ImmunoResearch), Vec-
tastain ABC Elite solution (1:1000; 1 h; PK-6100, Vector Laboratories),
biotinylated tyramide with H2O2 (1:1000 and 0.006%, respectively;
0.5 h), and, finally, Alexa Fluor 594-streptavidin (1:500, 12 h; S-11227,
Invitrogen). To visualize the cholinergic neurons, the sections were in-
cubated in FITC-donkey anti-goat IgG (dilution, 1:1000; overnight; cat-
alog #711-095-152, Jackson ImmunoResearch). Full sets of sections
(which means every fourth sections from each brain with 50 m gaps
between consecutive sections) were processed for the detection of pan-
GlyR immunoreactivity in cholinergic neurons of the mouse BF. Each
of the subdivisions was scanned in the confocal microscope, and 5–10
cells per regions were investigated for colocalization.
Tract tracing and mapping of retrogradely labeled neurons. To label
glycinergic neurons projecting to forebrain, GLYT2-GFP mice (n 12)
were given cholera toxin B (CTB; 0.5% solution; catalog #103, List Bio-
logical Laboratories) or Fluoro-Gold (2.5–5.0% FG, diluted in distilled
water; Fluorochrome; but see Schmued and Fallon, 1986) via unilateral
iontophoresis (5 A, 7 s on-off) into the BF for 20 min. For targeting
different subdivisions, the following stereotaxic coordinates were used,
respectively, with reference to the bregma (B) planes: MS: anteroposte-
rior, 0.61 mm; mediolateral, 0.0 mm; dorsoventral, 4 mm; HDB:
anteroposterior, 0.37 or 0.02 mm; mediolateral, 0.80 or 1.40
mm; dorsoventral, 4.90 or 5.00 mm (Paxinos, 2013); and VP/SI:
anteroposterior, 0.13 mm; mediolateral, 1.20 mm; dorsoventral,
4.25 mm. After a 6–10 day transport time, animals were deeply anes-
thetized and perfused first with 20 ml of PBS, followed by 0.1 M PBS
containing 4%PFA. The brains were removed, immersed in 30% sucrose
for 1–2 d, and frozen on dry ice, and 25-m-thick coronal sections were
cut from the blocks of the forebrain 1.3 and 1.3 mm from bregma
and the brainstem expanding between bregma 2.9 and 8 mm on a
freezingmicrotome. The sections were divided into four sequential pools
(20–22 sections of the forebrain and 45–50 sections of the brainstem in
each set with 75 m gaps between consecutive sections). The location of
CTB injection sites and the distribution of CTB-containing glycinergic
neurons in the brainstem were studied in double-immunolabeled sec-
tions. A set of sections from each brain was pretreated first with 0.5%
H2O2 and 0.5%TritonX-100 in PBS for 15min and then 2%NHS in PBS
for 20 min. They were then incubated in the goat anti-CTB antiserum
(catalog #703, List Biological; RRID:AB_2313637) at 1:2000 for 2 d at
4°C. After washes in PBS, they were immersed in CY3-donkey anti-goat
IgG (1: 2000; Jackson ImmunoResearch) and incubated for 2 h at room
temperature. Sections containing labeled cells with Fluoro-Gold were
mounted and coverslipped with Vectashield mounting medium (Vector
Laboratories), as described before. Formapping, the glycinergic neurons
retrogradely labeled from the different BF regions every fifth sections
with 75m gaps in between were processed, and the sections containing
the anatomical region (e.g., five sections/brain for the raphemagnus; n
6) with double-labeled cells (GLYT2-GFP and CTB-IR) were selected
and photographed in the confocal microscope. The border of the ana-
tomical regionwas defined (based on the corresponding atlas image) and
each single- or double-labeled cell was counted in the region of interest to
avoid problems arising from a potential uneven distribution of retrograde-
labeled cells. Perikarya with a clear sign of nuclear presence were con-
sidered during the quantification, and colocalization of the signals
was determined manually by turning the color channels alternatively
on and off.
Immunohistochemical controls. The specificities of the ChAT, GLYT1,
GLYT2, and GlyR primary antisera have been reported previously; thus,
controls included preabsorption of the ChAT antibody with the corre-
sponding protein antigen (Motts et al., 2008), immunoblot confirmation
ofGLYT2 andGlyR bands at the expectedmolecular weight in samples of
transfected cells and mouse brain tissue (Hondo et al., 2011), and detec-
tion of GLYT1 mRNA signal in brain sections in comparative distribu-
tion to GLYT1 immunoreactivity (Kallo´ et al., 2008).
In the current study, the ChAT and GLYT2 antibody labeling did not
reveal structures other than those detected by transgenic eGFP fluores-
cence expressed under the promoter of ChAT or GLYT2. The specific
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binding of the pan-GlyR antibody to the glycine receptors was con-
firmed by a second 2 subunit-specific antiserum (catalog #sc-17279,
Santa Cruz Biotechnology; RRID:AB_2110230) detected in the same dis-
tribution in the BF. Increasing dilutions of the primary antisera resulted
in a commensurate decrease and eventual disappearance of the immu-
nostaining; omission of the primary antibodies or their preabsorption
with corresponding peptide antigens resulted in a complete loss of the
immunostaining. The secondary antibodies used here were designed for
multiple labeling and were preabsorbed by the manufacturer with Igs
from several species, including the one in which the other primary anti-
body had been raised.
In vitro electrophysiology
Animals, slice preparation, and chemicals.Mice expressing tdTomato flu-
orescent proteins in a ChAT-dependent way (n  26) were used from
both sexes. After decapitation of the animal and removal of the brain,
200-m-thick coronal forebrain slices were prepared using a Microm
HM 650 V Vibratome (Microm International) in ice-cold low-Na artifi-
cial CSF (aCSF) with the following ingredients (in mM): sucrose 130,
glycerol 60, NaCl 25, KCl 2.5, NaHCO3 26, glucose 10, NaH2PO4 1.25,
CaCl2 2, MgCl2 1, myo-inositol 3, ascorbic acid 0.5, and sodium-
pyruvate 2, pH 7.2. After cutting, slices were incubated in normal aCSF
for 60 min on 37°C. The concentration of NaCl was elevated in normal
aCSF to 120 mM, while sucrose and glycerol were omitted from the solu-
tion. All chemicals were purchased from Sigma-Aldrich, unless stated
otherwise. Brain slices were visualized with an Axioskop Microscope
(Carl Zeiss). The microscope was equipped with a fluorescent imaging
system (Till Photonics) containing a xenon bulb-based Polychrome V
light source, a CCD camera (SensiCam, PCO AG) an imaging control
unit, and the TillVISion software (version 4.0.1.3; T.I.L.L. Photonics).
Patch pipettes with 5 M pipette resistance were fabricated and filled
with a solution containing the following (in mM): KCl 120, NaCl 5,
HEPES 10, EGTA 2, CaCl2 0.1, Mg-ATP 5, Na3-GTP 0.3, Na2-phos-
phocreatinine 10, and biocytin 8, pH 7.3. In a set of experiments, KCl was
replaced with equimolar K-gluconate. To detect postsynaptic currents,
whole-cell patch-clamp recordings were performed using an Axopatch
200A Amplifier (Molecular Devices) in voltage-clamp configuration at
holding potentials120,100,60,40, and 0 mV. Action potential
firing pattern was recorded in current-clamp configuration; the resting
membrane potential was set to 75 mV, and current injections were
used from30 to120 pA in 10 pA steps. All recordingswere performed
in normal aCSF at room temperature. Data acquisition was achieved
using theClampex 10.0 software (MolecularDevices), while data analysis
was performed using Clampfit version 10.0 (Molecular Devices) and
Mini Analysis (Synaptosoft) programs. When the latter software was
used for event detection, traces, where all events were pharmacologically
inhibited, were used for setting detection parameters; fromcell to cell, the
detection threshold of the events varied from 7 to 15 pA (12.3 0.5 pA).
Other parameters were set as follows: period to search a local maximum,
80ms; time before a peak for baseline, 20ms; area threshold, 5 fC; period
to search a decay time, 40 ms; and period to average a baseline, 1 ms.
Pharmacology and visualization of the labeled neurons.When recording
glycinergic IPSCs, slices were continuously perfused with 10 M 2,3-
dihydroxy-6-nitro-7-sulfonyl-benzo[f]quinoxaline (NBQX), 50 M
D()-2-amino-5-phosphonopentanoic acid (D-AP5; Tocris Cookson),
and 10M bicuculline to block ionotropic glutamatergic and GABAergic
neurotransmissions (GG Blocking Cocktail). This cocktail was later
completed with 1 M strychnine to show that the observed IPSCs are
strychnine sensitive. The neurons were filled with biocytin during the
electrophysiological recordings. The slices accommodating the filled
neuronswere fixed overnight (4%PFA in 0.1 M phosphate buffer; pH 7.4;
4°C). Permeabilization was achieved in Tris-buffered saline (in mM: Tris
base 8, Trisma HCl 42, and NaCl 150, pH 7.4) supplemented with 0.1%
Triton X-100 and 10%bovine serum (60min). The slices were incubated
in phosphate buffer containing streptavidin-conjugated Alexa Fluor 488
(1:300; Invitrogen) for 90 min. The cells were visualized using a Zeiss
LSM 510 confocal microscope (Carl Zeiss AG).
Experimental design and statistical analysis
Anatomical studies. Wild-type (n  21) and transgenic male mice
(GLYT2-eGFP, n 12; or ChATBAC-eGFP, n 3) were used to charac-
terize the cellular interaction in the BF potentially providing glycinergic
input to cholinergic neurons. Efforts were made to keep animal usage at
a minimum while ensuring representation of the different subdivisions
of the BF in the analysis of morphological interactions of receptors or
inputs on cholinergic neurons. Every fourth (with 50 m tissue gaps)
sectionwas processed from each brain for a certain type of immunostain-
ing, and for each of the BF subdivisions confocal microscopy was used to
scan 5–10 cholinergic cells for colocalization of receptor on cholinergic
neurons. To better define anatomical regions, immunostained sections
were compared with their matching counterstained pairs. For synaptic
interactions of glycine axons, 32 synapses were identified with cholin-
ergic profiles from randomly selected close appositions (n  84). For
assessing the importance of brainstem sites projecting to the cholinergic
forebrain, each single- and double-labeled neuron was counted in sets of
1:5 series, with 75mgaps between consecutive sections. A set of sections
from brains with different BF injection sites (see Fig. 7) of the retrograde
tracer were analyzed. The percentages of the retrogradely labeled glycin-
ergic neurons in the nucleus raphe magnus of six animals were averaged
from counts of 30 sections (5 sections/brain). Immunohistochemical
controls involved tests to exclude false negativity and positivity poten-
tially generated either by the animal models, reagents, or methods used
(see Immunohistochemical controls for details).
In vitro electrophysiology. ChAT-tdTomato mice (n  26) were used
from both sexes. Slices were cut from the basal forebrain region and used
to record from cholinergic neurons (n 46) of the different subdivisions
of the basal forebrain. One neuron was patched in each slice. All data
represent themean SEM. Postsynaptic currents detected by whole-cell
patch-clamp recordings in voltage-clamp configuration were character-
ized for amplitude and frequency under control conditions and pharma-
cological interventions. To distinguish early-firing (EF) and late-firing
(LF) cholinergic neurons, the action potential firing pattern was re-
corded in current-clamp configuration. Statistical significance was de-
termined using Student’s t test. Two-sample Kolmogorov–Smirnov test
was used for comparison of amplitude, rise time, and decay time of IPSCs
in different neuronal populations. The level of significance was p	 0.05.
Results
Cholinergic neurons are immunoreactive for
glycine receptors
Using a pan-GlyR antibody, immunoreactive puncta were de-
tected in all subdivisions of BF. The ventral pallidum showed the
weakest pan-GlyR immunoreactivity; no obvious difference
could be observed in the intensity of staining in the MS, VDB/
HDB, SI, and basal nucleusMeynert. The deposited immunohis-
tochemical reaction product often delineated cellular borders
even inweakly labeled areas (Fig. 1A–C). Confocal microscopic
analyses of double-labeled sections identifiedGlyR-IR sites at the
periphery of most cholinergic neurons (Fig. 1D–E), indicating
that glycine can directly influence BF cholinergic functions.
Cholinergic neurons exhibit strychnine-sensitive IPSCs
Whole-cell patch-clamp recordings were performed on 36 ge-
netically identified cholinergic neurons from the medial septal
nucleus, the horizontal diagonal band, the ventral pallidum, the
substantia innominate, and the lateral nucleus of the diagonal
band (LDB). To increase the amplitude of chloride currents, a
KCl-based internal solution was applied in the recording pi-
pettes. Thirty-one of the neurons displayed bicuculline-resistant,
strychnine-sensitive spontaneous IPSCs with an average fre-
quency of 0.81 0.25 101 Hz (range, 0.04–9.22 101 Hz;
t(36) 4.68, p 0.0008, paired t test, comparedwith control) and
an average amplitude of 15.23  1.38 pA (range, 8.4–29.9 pA;
t(39) 5.28, p 0.0009, paired t test, compared with control; Fig.
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2A–D). A mean of 11.2  2.7% of all synaptic events remained
detectable after application of the GG blocking cocktail, but were
completely eliminated by strychnine added into the incubating
medium (for frequency: t(23)  3.39, p  0.001; for amplitude:
t(23) 18.47, p 1.35823 10
15, paired t test). The number of
putative glycinergic IPSCs analyzed per cells varied from 6 to 153
events during the recording periods.However, the distribution of
the IPSC frequency was not uniform: among the recorded cells,
there was a slight ventrolateral–dorsomedial gradient of IPSC
frequency (Fig. 2E).
To ensure that the strychnine-sensitive events were chloride
currents, the reversal potential had also be examined. First, re-
cordings were performed by using KCl-filled pipettes at holding
potentials of 60 and 100 mV. To avoid bias in determining
the average amplitude of events by involving low-amplitude events
appearing at 100 mV due to higher driving force for chloride,
the amplitudes of the three largest events were considered from
each recording; their average values were plotted against the
holding potentials. Recordings were alsomade on40 and 0mV
holding potentials, but no events could be detected, very likely
because amplitude of events at this range of holding potentials fell
under the detection threshold. Reversal potential was determined
by the intersection of the linear fit of the averaged data with the
abscissa of membrane potentials. The extrapolated value (5.5
mV; n  8) was close to the calculated equilibrium potential of
chloride (0.6 mV; Fig. 2G). Based on these reversal potential
values, it is very likely that the recorded bicuculline-resistant
events were not based on potassium currents, as the calculated
reversal potential for potassium would be 99.1 mV in these
conditions. Of note, mixed cationic conductances (Kandel et al.,
2013) could have still served as a background of the observed
events. To exclude this possibility, KCl was replaced with K-gluco-
nate in the internal solution of the recording pipette (n  10),
resulting in a calculated equilibrium potential for chloride at
83.1 mV. Contrasting the traces recorded with KCl-containing
pipettes that show negative-going events at60 mV holding po-
Figure 1. Distribution of GlyR-IR sites in the basal forebrain detected by a pan-GlyR antibody. A, The punctate appearance of GlyR-immunoreactivity (revealed by NiDAB) often delineates
cellular borders in the strongly labeled accumbens core, in themedium labeledHDB, aswell as in theweakly labeled ventral pallidum (bregma level, 0.73). Theboxedarea ofHDB is furthermagnified
in B showing GlyR immunoreactivity in the perikaryon as well as in the processes of cells. C, A high-power photograph of a single cell, with GlyR-IR sites primarily distributed at the periphery of the
cell (arrows).D, E, Confocal microscopic images of two optical slices (0.75m) of a ChAT-eGFP neuron exhibiting GlyR-IR sites at the contour of the cell (arrows). aca, Anterior commissure, anterior
part; AcbC, accumbens nucleus, core region; AcbSh, accumbens nucleus, shell region. Scale bars: A,B, 100m; C, 10m;D, E, 5m. Contrast and brightness were adjusted by the Curves function
of Adobe Photoshop 5.1.
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tential in the presence of the GG blocking cocktail (Fig. 2B),
negative-going events were almost completely absent (0.01 
0.007  101 Hz) when K-gluconate-filled pipettes were used
(Fig. 2H). Application of the GG blocking cocktail significantly
reduced the appearance of such events (t(6)  2.97, p  0.01,
paired t test; from 1.41 0.47 101 Hz seen in control condi-
tions). In turn, bicuculline-resistant, positive-going events were
seen in seven cases with an average amplitude of 12.6  1.1 pA
(Fig. 2H). The frequency of these positive-going events (0.47 
0.13 101 Hz) and the negative-going events recordedwith the
KCl-containing pipettes were not significantly different (t(29) 
0.74, p 0.25, two-sample t test). These experiments support the
hypothesis that the strychnine-sensitive events recorded were
truly chloride currents. By using the K-gluconate-filled pipettes,
bicuculline-resistant events were recorded at 120, 60, and
40 mV holding potentials (n 5), and the average amplitudes
were plotted against the holding potentials, as described above.
The linear fit crossed the abscissa at86.9 mV, which is close to
the reversal potential of chloride calculatedwith theNernst equa-
tion (83.1mV); thus, mixed cationic currents as background of
these events were clearly excluded (Fig. 2I).
The firing pattern of the neuronswas also recorded in 28 cases,
using current-clampmode and depolarizing current injections in
10 pA steps, and the action potential firing pattern was evaluated
at the step using 60 pA current injection. Twenty-two of the
neurons proved to be EF (Fig. 3A,C), and the other 6 were LF
(Fig. 3B,C). In accordance with the findings of Unal et al. (2012),
these neurons possessed similar input resistance values (606.6
89 M for the EF and 628.3  79 M for the LF; t(12)  0.174,
p 0.43, two-sample t test) but showed significant differences in
the delay of the first action potential (43.4  5.4 ms for EF and
247.9 19.8 ms LF; t(16) 10.06, p 1.26 10
8, two-sample
t test). When the glycinergic sIPSCs (sIPSCGs) were compared in
EF and LF neurons, significantly longer interevent intervals were
seen in LF neurons (p  0.018; Kolmogorov–Smirnov test). In
contrast, EF neurons (n 20) showed sIPSCGs with significantly
higher amplitude (p  3.15  107), shorter rise time (p 
0.008) and longer decay time (p 2.19 104) than LF cholin-
Figure 2. Glycinergic IPSCs recorded on cholinergic neurons in the basal forebrain. A, A 10-s-long representative trace of spontaneous (excitatory and inhibitory) postsynaptic currents recorded
in normal aCSF. B, Inhibitors of ionotropic glutamate receptors (NBQX, D-AP5) and GABAA receptors (bicuculline) did not fully abolish postsynaptic currents. C, Adding strychnine to the recording
cocktail blocked all events.D, Bar chart diagrams of the frequency and amplitude of the recorded events (average SEM) in normal aCSF (N, hollow), with NBQX, D-AP5, and bicuculline (C; green)
andwith additional strychnine application (CS; gray). All differences were statistically significant ( p	 0.001). Cumulative histogram of the interevent interval and amplitude of synaptic events
in normal aCSF (black) or in the presence of the NBQX-, D-AP5-, and bicuculline-containing blocking cocktail (green). All differences were statistically significant (Kolmogorov–Smirnov test; p	
0.001). E, Positions of the recorded neuronal somata in the basal forebrain shown by dots. Differences in the frequency of the strychnine-sensitive events are color coded. The mouse forebrain is
reconstructed, and the distribution of recorded cells is shown from twodifferent angles (axial and lateral views; based on themouse brain atlas (Paxinos, 2013). F, Confocal image of a biocytin-filled
cholinergic neuron from the HDB. The inserts aremagnified images of the boxed areas and show secondary dendritic processes with scattered spines (arrows and asterisks).G, Determination of the
reversal potential of the strychnine-sensitive events with KCl-based pipette solution (ECl
0.6 mV). Black dots, Average SEM of the three largest events of each trace; dashed line, linear fit
of the average values; gray dot, calculated equilibrium potential of chloride. Representative current traces belonging to different holding potentials are also included in the inserts.H, Current traces
recordedwith KCl (ECl
0.6mV) andK-gluconate-based (ECl
83.1mV) pipette solutions. I, Determination of the reversal potential of the strychnine-sensitive eventswith K-gluconate-
based pipette solution (ECl
83.1mV). Black dots, Average SEM of the three largest events of each trace; gray line, linear fit of the average values; gray dot, calculated equilibrium potential
of chloride. Current traces recordedwith K-gluconate-based (ECl
83.1mV) pipette solutions at different holding potentials (120,60, and40mV; n 7) are also shown in the inserts.
Scale bars: E, 1 mm; F, 20m; small insert, 10m.
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ergic neurons (n 6; Kolmogorov–Smirnov test; two of the early
firing neurons did not show IPSCGs and were excluded from
evaluation of these parameters; Fig. 3D–F). When neurons lack-
ing sIPSCGs were included in the statistical analysis, due to the
variability of sIPSCG frequency, no significant difference was re-
vealed between EF and LF neurons in this parameter (0.33 
0.18 101 Hz for EF neurons and 0.5 0.16 101 Hz for LF
neurons).
Distribution of glycinergic (GLYT2-IR) axons in the BF
Although the location of glycinergic cell bodies is mainly re-
stricted to the spinal cord and the brainstem, the axonal projec-
tions from the brainstem reach most of the forebrain regions,
including the BF. By immunohistochemically labeling GLYT2,
the plasma membrane transporter of glycine, we detected a high
density of glycinergic axons in the mouse BF, including the areas
where ChAT-IR neurons are clustered [i.e., GLYT2-IR fibers
were observed in the MS, VDB, HDB, LDB, VP, SI, and the ex-
tension of the amygdala (EA); Fig. 4A–E]. Bright-field (Figs. 4F,
5A–C) and electron microscopic approaches (Fig. 5D–G) re-
vealed axosomatic and axodendritic connections between
GLYT2-positive axon terminals and ChAT-IR neurons. Analyses
of high-power images often revealedGLYT2-IR fiber varicosities,
with a central nonlabeled area indicating embedded processes of
target cells and concave joined surfaces (Fig. 5B,C, insets). At
the ultrastructural level, 32 synapses were identified with cho-
linergic profiles; GLYT2-IR axon terminals were found to sur-
round smaller-diameter as well as larger-diameter ChAT-IR
dendrites (Fig. 5E,F) and formed symmetric synapses with den-
dritic shafts (Fig. 5D–F; n 20) and perikarya (Fig. 5G; n 1). In
addition, the correlated bright-field (Fig. 6A) and electronmicro-
scopic (Fig. 6B–D) approach and analysis of serial ultrathin sec-
tions also revealed axospinous connections on somatic spines
(Fig. 6C; n 2) and dendritic spines (Fig. 6D; n 9).
Brainstem nuclei provide the BF with glycinergic input
To identify the source of glycinergic input to the BF, the retro-
grade tracers CTB or Fluoro-Gold were injected into the MS,
HDB, VP, and SI (Fig. 7A–D) of mice expressing GFP under the
control of GLYT2 promoter. Although the distribution of retro-
gradely labeled GFP-positive neurons varied from brain to brain
depending on the exact locations and sizes of injection sites, there
were brainstem areas and nuclei commonly labeled for the tracer
(Fig. 7E). The highest number of double-labeled neurons were in
Figure 3. Differences between the glycinergic sIPSCs recorded from early- and late-firing BF cholinergic neurons. A, Firing pattern of an early-firing neuron elicited by a 60 pA depolarizing
current injection.B, Firing pattern of a late-firing neuron, elicited by 60 pA depolarizing current injection. The dashed line indicates75mV. C, Statistical summary of the delay (time between the
beginningof the rheobase current injection and the first actionpotential, from75mVholdingpotential) of early-firing (E, black) and late-firing (L, red) neurons (***p	0.001).D, Representative
trace of glycinergic events from an early-firing neuron (black trace) and a late firing neuron (red trace). E, Glycinergic IPSCs from an early-firing (left) and a late-firing (right) cholinergic BF neuron.
Gray traces, individual IPSCs; black trace, average of spontaneous glycinergic IPSCs from an early firing neuron; red trace, average of spontaneous glycinergic IPSCs from a late firing neuron. F,
Statistical summary of the observed differences between early-firing (black) and late-firing (red) neurons with bar charts [black, early firing (E); red, late firing (L); average SEM] and cumulative
histograms. Interevent interval, time between two glycinergic IPSCs in seconds; amplitude differences of the glycinergic events in pA; rise, rise time; decay, decay time in milliseconds.
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Figure 4. A–E, Dual immunohistochemical labeling to identify the relationship between GLYT2-IR fibers and ChAT-IR neurons in the basal forebrain. Distribution of GLYT2/ChAT-IR cellular
profiles in the basal forebrain shown in coronal sections at five different rostrocaudal levels. Rich network of GLYT2-immunoreactive fibers is present in regions of the basal forebrain where
cholinergic neurons are located [i.e.,MS (Ch1), VDB (Ch2), HDB (Ch3), VP (Ch4), and SI (Ch4);Mesulamet al., 1983]. The rostrocaudal levels are given inmillimeters from the bregma, based upon the
mouse brain atlas (Paxinos, 2013). Amedium power image shows GLYT2-IR fiber varicosities adjacent to ChAT-IR soma (white arrowheads) and dendrites (black arrowheads) in the HDB. The inset
highlights one of these appositions. AA, Anterior amygdaloid area; ACo, anterior cortical amygdaloid nucleus; acp, anterior commissure, posterior limb; B, basal nucleus (Meynert); CeM, central
amygdaloid nu, medial; Cpu, caudate-putamen (striatum); CxA, cortex–amygdala transition zone; f, fornix; GP, globus pallidus; ic, internal capsule; IPACL, interstitial nucleus of the posterior limb
of the anterior commissure, lateral part; IPACM, interstitial nucleus of the posterior limb of the anterior commissure, medial part; LH, lateral hypothalamic area; LPO, lateral preoptic area; MeA,
medial amygdaloid nucleus, anterior part; MPA, medial preoptic area; ns, nigrostriatal bundle; och, optic chiasm; opt, optic tract; PLH, peduncular lateral hypothal; Rt, reticular nucleus (prethala-
mus); SIB, SI, basal part; sm, stria medullaris; Tu, olfactory tubercle; VLH, ventrolateral hypothalamic nucleus; VLPO, ventrolateral preoptic nucleus; ZI, zona incerta. Scale bars: A–E, 500 m;
F, 25m. Contrast and brightness were adjusted using the Curves function of Adobe Photoshop 5.1.
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the raphe magnus (Fig. 7E–I; 25  7.4% of all GFP neurons,
n  6). Retrogradely labeled GFP-positive neurons were also
commonly present in the different parts of the pontine reticular
nucleus and the gigantocellular reticular nucleus. A few cells
could also be detected in the periaqueductal gray (Fig. 7E).
GLYT1 is also present in the BF
In BF regions, immunoreactivity for GLYT1was very strong (Fig.
8A–F). Immunohistochemical colabeling with the astroglial
marker glutamine synthetase revealed that GLYT1 is primarily
present in astrocytes (data not shown). Confocal microscopic
analysis detectedGLYT1-IR thin astrocytic processes in the vicin-
ity of axon varicosities in apposition to cholinergic neurons (Fig.
9A–D) in all studied BF regions. At the ultrastructural level, the
presence of GLYT1 immunoreactivity in thin glial processes was
confirmed, often adjacent to axon terminals establishing asym-
metric or symmetric synapse with the cholinergic neurons (Fig.
10A–D).
Discussion
According to the classical concept of the ascending arousal sys-
tem (Nauta and Kuypers, 1957), a major branch of the complex
pathways from the rostral pons and caudal midbrain reaches the
hypothalamus and the BF and mediates activating function for
these brain regions. Subsequent studies identified inputs from
the locus ceruleus; from the adrenergic, dopaminergic brainstem
neurons; and from the parabrachial nucleus to synapse with the
BFneurons, includingcholinergic, glutamatergic, andparvalbumin-
containing neurons using electron microscopy (Za´borszky et al.,
1993,1999; Gaykema and Zaborszky, 1997; Hajsza´n and Zaborszky,
2002) or viral tracing (Fuller et al., 2011; Kaur et al., 2013; Anaclet
et al., 2014). The current morphological and functional analyses
identified for the first time an ascending glycinergic pathway
from the nucleus raphe magnus and neighboring reticular for-
mation of the pons to the BF cholinergic neurons. Glycine
exhibits bicuculline-resistant, strychnine-sensitive sIPSCs on
BFC neurons.
Glycine is a major transmitter in the BF
The current data support a substantial glycinergic input to cho-
linergic neurons in all subdivisions of the BF. Approximately
80% of the recorded neurons, selected randomly from themedial
septal nucleus, the horizontal diagonal band, the ventral palli-
dum, substantia innominate, and the lateral nucleus of the diag-
onal band, displayed bicuculline-resistant, strychnine-sensitive
spontaneous IPSCs. Based on the reversal potential calculations
Figure 5. Bright-field and electron microscopic images of GLYT2-IR fibers in apposition to ChAT-IR neurons of the basal forebrain. A–C, Varicose GLYT2-IR axons establish axosomatic and
axodendritic connectionswith ChAT-IR neurons in themedial septum (A), the nucleus of the horizontal limb of the diagonal band (B), and the basal nucleus (C). The axon varicosities often surround
or embed neural profiles, as demonstrated by the insets, showing central lighter areas in certain axon varicosities. D–G, The appositions between GLYT2-IR axons and ChAT-IR dendrites (D–F ) or
soma (G) often proved to be synaptic connections (black arrows) showing characteristics of the symmetric types. Scale bars: A–C, 10m; D–G, 500 nm.
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of the events, these IPSCs were very likely chloride currents, as
they were clearly distinguished from potassium currents and
mixed cationic conductances. Although a slight difference in the
frequency range of IPSCs could be observed in dorsomedially
versus ventrolaterally distributed cells, the frequent appearance
of cholinergic neurons showing pan-GlyR immunoreactivity or
a close relationship with GLYT1 or GLYT2-IR cell processes in-
dicates a nonselective, general role for glycine in all major subdi-
visions of the BF. However, these do not exclude the possibility of
prevailing differences within glycinergic input of specific cho-
linergic cell populations. For example, EF and LF cholinergic
neurons were distinguished (Unal et al., 2012) with putative
functional consequences. It was suggested, that the EF neurons
are more suitable for phasic changes in acetylcholine release as-
sociated with attention, and the late firing neurons could support
general arousal by maintaining tonic acetylcholine levels. Com-
parison of the glycinergic sIPSCs of these subtypes in the current
study revealed a significantly higher amplitude and longer decay
time in EF than in LF neurons, indicating a potential difference in
the somatodendritic, proximodistal location of their glycinergic
Figure 6. GLYT2-IR axon terminals synapsewith somatic (C) and dendritic (D) spines of cholinergic neurons in the HDB.A, High-powermicrograph of the immunohistochemically double labeled
and epoxy-embedded section shows multiple contacts (arrowheads) between GLYT2-IR axon varicosities and a ChAT-IR neurons (highlighted in red). B–D, The outlined areas (labeled with
C and D) of the low-power electron micrograph are shown in further magnified images of consecutive ultrathin sections (C–D). Dendritic spines are embedded in and synapsing (black arrows)
with GLYT2-IR axon terminals; the spine neck identifies the dendritic spine (stars) in connection with the ChAT-IR neuron. Scale bars: A, 5m; B, 2m; C–D, 500 nm.
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synapses or in the general membrane properties determining
propagation characteristics of IPSCs. The responses of EF and LF
cholinergic neurons to glycine raise a possibility for the involve-
ment of this inhibitory neurotransmitter in both attention regu-
lation and arousal.
Origin of glycine input and putative colocalization
with GABA
The BF does not contain glycinergic neurons; they are primarily
located in the brainstem and spinal cord. Only the axonal projec-
tions reach the forebrain areas, as was shown in transgenic ani-
Figure 7. Location of basal forebrain-projecting glycinergic neurons revealed by iontophoretic injection of the retrograde tracer CTB or Fluoro-Gold into different subdivisions of the BF.
A–D, Representative CTB-IR (#2875, #2874, and #2877) and Fluoro-Gold (#3030) injection sites plotted in basal forebrain section images and the corresponding atlas figures (based on Paxinos,
2013). E, General overview of glycinergic projections from the brainstem to basal forebrain showing themost abundant input from the raphemagnus and its neighboring nuclei (red arrow) and the
least number of retrogradely labeled cells locating in the periaqueductal graymatter (PAG; light red arrow).F, Retrogradely labeled cells detected in the pons, containingGLYT2-GFP-expressing cells
in the raphe magnus nucleus (RMg), pontine reticular nucleus ventral part (PnV) and caudal part (PnC), and raphe interpositus nucleus (RIP). The outlined area is further magnified in G–I to
demonstrate double-labeled neurons projecting to the BF.G–I, The single-labeled (white arrow) and double-labeled cells (black arrows) are shown in corresponding single (G,H ) and dual (I ) color
images. Gi, Gigantocellular reticular nucleus; GiA, gigantocellular reticular nucleus,part; GiV, gigantocellular reticular nucleus, ventral; PnO, pontine reticular nucleus, oral part; py, pyramidal tract;
Rpa, raphe pallidus nucleus; Tz, nucleus of the trapezoid body. Scale bars: A–D, F, 100m; G–I, 25m.
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mals expressing GFP under the control of GLYT2 promoter
(Zeilhofer et al., 2005). In the current study, the same animal
model was used to localize the glycinergic neurons projecting to
theBF. Relatively few areas in the brainstemwere found to exhibit
cells double labeled for GFP and the retrograde tracer CTB
subunit or Fluoro-Gold. The majority of glycine-containing
projecting neurons were found in the nucleus raphe magnus and
the gigantocellular reticular nucleus. These nuclei have been re-
ported to establish a descending pathway responsible for muscle
atonia during REM sleep (Holstege and Bongers, 1991; Kato et
Figure 8. Dual immunohistochemical labeling of GLYT1-IR structures (arrowheads) in the vicinity of ChAT-IR neurons. A–E, Distribution of GLYT1- and ChAT-IR cellular profiles in the basal
forebrain shown in coronal sections at five different rostrocaudal levels. Cholinergic neurons are embedded in GLYT1-IR puncta present in all major regions of the basal forebrain. The rostrocaudal
levels are given in millimeters from the bregma, based upon the mouse brain atlas (Paxinos, 2013). F, The medium power reveals a patchy arrangement of GLYT1-IR puncta resembling the shape
of astrocytes. Many IR puncta are in close vicinity to ChAT-IR neurons (arrowheads). st, Stria terminalis; STLP, bed nucleus of the stria terminalis, lateral division, posterior part; STLV, bed nucleus of
the stria terminalis, lateral division, ventral part; STMV, bed nucleus of the stria terminalis, medial division, ventral part. Scale bars:A–E, 500m; F, 50m. Contrast and brightness were adjusted
by the Curves function of Adobe Photoshop 5.1.
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al., 2006). Although the projection of GABA/glycinergic neurons
from these nuclei to the spinal cord has been demonstrated, re-
cent findings emphasize the primary role of glutamatergic neu-
rons in these nuclei in indirectly inhibiting the motoneurons via
spinal cord interneurons during REM sleep (Vetrivelan et al.,
2009). Further studies are required to clarify the function of the
ascending glycinergic pathways from these REM sleep-active
nuclei to the BF. It would be interesting to find out whether
bifurcating collaterals of the same cell bodies project to the
spinal cord and BF cholinergic neurons, as such a scenario was
implicitly suggested by demonstrating bifurcating axons orig-
inating from cell bodies in the pontine reticular formation
reaching the anterior horn of the spinal cord and the hypo-
thalamus using the classical Golgi technique (Scheibel, 1958).
During embryonic development, nearly all inhibitory neurons
in caudal brain regions express GLYT2, indicating that glycin-
ergic neurons are capable of coreleasing GABA. After birth,
the level of cotransmission falls but still remains at 40% in
adulthood (Rahman et al., 2015). It remains to be determined
whether glycinergic neurons projecting to the BF contain
GABA in their axons, since a mixed glycinergic/GABAergic
input and cell-specific expression of glycine receptors and
Figure 9. 3D reconstruction from the confocal image of neural structures in a section immunohistochemically labeled for ChAT (green), GLYT1 (red), and GLYT2 (blue). A, GLYT2-IR varicose
processes are in apposition to theChAT-IR cell bodyor processes (arrows). GLYT1-positive elements becomeassociatedwith surface areas of ChAT-IRneurons, includingareasnear apposingGLYT2-IR
terminals.B,C, Theoutlined areas are furthermagnified and rotated inB andC. In addition, theGLYT2-IRprocesses aremade semitransparent to demonstrate apposing surfaces. The inset inC shows
the overlapping structures from the side and the color generated by the differently labeled processes at the white line.
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GABAA receptors would indicate the capability for cholinergic
neurons to shape their inhibitory control.
Functional considerations
GLYT2-IR axon terminals were found on ChAT-IR perikarya, as
well as smaller- and larger-diameter cholinergic dendrites, in-
cluding spines on both the soma and dendrites of cholinergic
neurons. Inhibitory synapses often appear on the soma and the
proximal dendrites of target cells, in a position to efficiently block
the generation of action potentials. Their presence onmore distal
dendritic branches, which was frequently found in the current
study, was indicated to exert a less powerful but still significant
inhibitory influence on target cells, involving plasticity (Chiu et
al., 2013). Spine-like processes were observed inmost biocytin-
filled mouse cholinergic neurons (Fig. 2F ) and can also be
demonstrated in juxtacellularly filled or immunostained rat BFC
neurons at the ultrastructural level (A. Duque and L. Zaborszky,
unpublished observation). It remains to be determined whether
glycinergic synapses detected on the spines of the soma and the
proximal dendrites (Fig. 6) counterbalance excitatory inputs im-
pinging on adjacent dendritic segments. Spine morphology and
synaptic plasticity are regulated by the cytoskeletal and scaffold-
ing protein actin (dos Remedios et al., 2003), and its dysfunction
is thought to be critical in amyloid-induced cholinergic cell loss
in Alzheimer’s disease (Song et al., 2002; Maloney et al., 2005).
Organophosphate insecticides were shown to induce a concentration-
dependent reduction of spine-like processes in BFC neurons (Del
Pino et al., 2016), which is accompanied by the alteration ofNMDA
receptors. Unbalanced NMDA receptor-mediated signaling results
in cognitive andmemorydysfunctions, and it is supposedly the lead-
ing pathological process in many neurological and neurodegenera-
tive diseases (Gu et al., 2014).
Figure 10. A–D, Electron microscopic images of thin GLYT1-IR astrocytic processes (labeled with silver-gold particles) in the vicinity of nonlabeled neurons (A) and ChAT-IR neurons
(labeled with DAB; B–D). The GLYT1-IR processes (highlighted in blue) appear adjacent to nonlabeled axon terminals synapsing (arrows) with a ChAT-IR perikaryon (C) or dendrite (B, D).
Scale bars, A, 1m; B–D, 250 nm.
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It seems that either hyperfunction or hypofunction of this
receptor can evoke glutamate toxicity in vulnerable parts of the
CNS (Newcomer et al., 2000); the reason for that may be in the
different signaling pathways recruited by the two major sub-
populations, the synaptic and extrasynaptic pools of NMDA
receptors. Although there are some contradictory data in this
regard, the apparent agreement is that in addition to the physio-
logical signaling, glutamatergic transmission via synaptic NMDA
receptors is neuroprotective, whereas transmission via nonsyn-
aptic NMDA receptors is excitotoxic (Papouin et al., 2012). Gly-
cine is also a coagonist on NMDA receptors, although D-serine
released by astrocytes can also occupy the glycine-binding site on
the NMDA receptors. However, D-serine acts at synaptic NMDA
receptors and glycine acts as their extrasynaptic counterparts (Pa-
pouin et al., 2012). The high level of GLYT1 in BF (Fig. 10; Kallo´
et al., 2008) suggests a very tight control on the extracellular levels
of the coagonist glycine. It still needs to be clarified whether gly-
cine influences NMDA-mediated currents on cholinergic neu-
rons and thereby contributes to BF plasticity and learning.
Concluding remarks
In summary, the detection of (1) a rich network of glycinergic
axons in connection with the cholinergic neurons in the different
subregions of the BF; (2) symmetric glycinergic synapses on the
perikaryon and both the proximal and distal dendritic branches
of BFC neurons; and (3) bicuculline-resistant, strychnine-sensitive
postsynaptic events indicate a general inhibitory role for glycine
in the regulation of BFC functions. It remains for future studies to
explore whether specific behavioral conditions are linked with
glycine release in the BF and whether glycine could act as a mod-
ulator of NMDA receptor functions and thus could contribute to
the vulnerability of cholinergic neurons in Alzheimer’s disease or
related neurodegenerative diseases.
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